MicardisPlus 40 mg/12.5 mg tablets

Company
Boehringer Ingelheim Limited
Active Ingredient
Dosage Form
Tablet
Legal Category
B - prescription, may be renewed
Date of revision
03/2025

*further information is available on request to the holder of the authorisation or in the SPC

Licence number Strength ATC Code Dosage Form
EU/1/02/213/001 40 mg/12.5 milligram(s) C09DA, C09DA07 Tablet
EU/1/02/213/002 40 mg/12.5 milligram(s) C09DA, C09DA07 Tablet
EU/1/02/213/003 40 mg/12.5 milligram(s) C09DA, C09DA07 Tablet
EU/1/02/213/004 40 mg/12.5 milligram(s) C09DA, C09DA07 Tablet
EU/1/02/213/005 40 mg/12.5 milligram(s) C09DA, C09DA07 Tablet
Licence number
EU/1/02/213/001
Strength
40 mg/12.5 milligram(s)
ATC Code
C09DA, C09DA07
Dosage Form
Tablet
Licence number
EU/1/02/213/002
Strength
40 mg/12.5 milligram(s)
ATC Code
C09DA, C09DA07
Dosage Form
Tablet
Licence number
EU/1/02/213/003
Strength
40 mg/12.5 milligram(s)
ATC Code
C09DA, C09DA07
Dosage Form
Tablet
Licence number
EU/1/02/213/004
Strength
40 mg/12.5 milligram(s)
ATC Code
C09DA, C09DA07
Dosage Form
Tablet
Licence number
EU/1/02/213/005
Strength
40 mg/12.5 milligram(s)
ATC Code
C09DA, C09DA07
Dosage Form
Tablet

Boehringer Ingelheim Limited

The Crescent Building, , Northwood, Santry, Dublin 9

Email
medinfo.ukie@boehringer-ingelheim.com